| P2093 | author name string | Bernard A | |
| | Belin MF | |
| | Akaoka H | |
| | Giraudon P | |
| | Pagenstecher A | |
| | Khuth ST | |
| | Verlaeten O | |
| P2860 | cites work | Furin-dependent intracellular activation of the human stromelysin-3 zymogen | Q28115242 |
| | Metalloproteinases and their inhibitors in matrix remodeling | Q28305537 |
| | Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases | Q28611036 |
| | Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity | Q28618997 |
| | Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2 | Q28619052 |
| | Alteration of the leptin network in late morbid obesity induced in mice by brain infection with canine distemper virus | Q33649280 |
| | Extracellular matrix degradation by metalloproteinases and central nervous system diseases | Q33737455 |
| | Proteolysis and cell migration: creating a path? | Q33744936 |
| | Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte | Q33858422 |
| | The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. | Q34384684 |
| | Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter | Q34784977 |
| | The matrix-degrading metalloproteinases | Q35535244 |
| | Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice | Q35745943 |
| | Cytokine-induced endogenous procollagenase stored in the extracellular matrix of soft connective tissue results in a burst of collagen breakdown following its activation | Q71773843 |
| | Tissue inhibitors of metalloproteinases and their cell growth-promoting activity | Q72790902 |
| | Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome | Q74452553 |
| | Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts | Q74454277 |
| | Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. | Q35765041 |
| | Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction | Q35847074 |
| | The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1 | Q36006767 |
| | RNAse protection assays for the simultaneous and semiquantitative analysis of multiple murine matrix metalloproteinase (MMP) and MMP inhibitor mRNAs | Q36885752 |
| | Sequence homology within the morbilliviruses. | Q36898593 |
| | T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: relevance to HTLV-I-induced neurological disease | Q39024473 |
| | Matrix metalloproteinase 9 (gelatinase B) in cerebrospinal fluid of HTLV-1 infected patients with tropical spastic paraparesis | Q39024476 |
| | Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): possible involvement in neurodegenerative processes | Q39024480 |
| | Tissue inhibitor of metalloproteinase 3, matrix metalloproteinase 9, and neopterin in the cerebrospinal fluid: preferential presence in HTLV type I-infected neurologic patients versus healthy virus carriers | Q39174197 |
| | Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis | Q39871557 |
| | Comparative aspects of pathogenicity of measles, canine distemper, and rinderpest viruses. | Q40290187 |
| | Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease | Q40423064 |
| | Inhibitory cytokines and cytokine inhibitors | Q40546579 |
| | Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene. | Q40893331 |
| | Matrix metalloproteinases in immunity. | Q40968642 |
| | Extracellular matrix-remodeling metalloproteinases and infection of the central nervous system with retrovirus human T-lymphotropic virus type I (HTLV-I). | Q41141833 |
| | TIMP-2 growth-stimulatory activity: a concentration- and cell type-specific response in the presence of insulin | Q41206319 |
| | Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface | Q41239020 |
| | Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons | Q41245798 |
| | Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum | Q41639433 |
| | ECM and cell surface proteolysis: regulating cellular ecology | Q41656253 |
| | Matrix metalloproteinases and diseases of the CNS. | Q41719486 |
| | Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes | Q42490282 |
| | Induction of MMP9 (92 kDa gelatinase) activity and expression of tissue inhibitor of metalloproteinase-2 mRNA (TIMP-2) in primitive neuroectodermal cells infected with retrovirus HTLV-I. | Q44036250 |
| | Selective induction of cytokines in mouse brain infected with canine distemper virus: structural, cellular and temporal expression | Q44280598 |
| | Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions | Q44310002 |
| | Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors | Q45258911 |
| | Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia | Q45747316 |
| | Inhibition of tyrosine hydroxylase expression within the substantia nigra of mice infected with canine distemper virus | Q45762636 |
| | Brain structures selectively targeted by canine distemper virus in a mouse model infection | Q45776079 |
| | Canine distemper infection in mice: characterization of a neuro-adapted virus strain and its long-term evolution in the mouse | Q45796111 |
| | Altered ratios of measles virus transcripts in diseased human brains | Q45830076 |
| | ECM signalling: orchestrating cell behaviour and misbehaviour. | Q45971375 |
| | Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients | Q46621005 |
| | Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid | Q47969608 |
| | Neuronal excitation-driven and AP-1-dependent activation of tissue inhibitor of metalloproteinases-1 gene expression in rodent hippocampus. | Q48106416 |
| | Differential expression of matrix metalloproteinases in bacterial meningitis | Q48147293 |
| | Diffusion constraints and neuron-glia interaction during aging. | Q48287948 |
| | Regional and differential expression of gelatinases in rat brain after systemic kainic acid or bicuculline administration | Q48345682 |
| | The gene family encoding the mouse ribosomal protein L32 contains a uniquely expressed intron-containing gene and an unmutated processed gene | Q48390212 |
| | Extracellular space structure revealed by diffusion analysis. | Q48457742 |
| | Zymographic measurement of gelatinase activity in brain tissue after detergent extraction and affinity-support purification | Q48616876 |
| | Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: evidence for developmental, immediate early gene, and lesion response. | Q48703291 |
| | Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40). | Q48829616 |
| | The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis | Q57584744 |
| | Leukocyte Gelatinase B Cleavage Releases Encephalitogens from Human Myelin Basic Protein | Q57584819 |
| | Neuronal IFN-gamma in tuberomammillary neurones | Q58852500 |
| | The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth | Q71188827 |
| | MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis | Q71354764 |
| | Matrix metalloproteinases degrade myelin basic protein | Q71485308 |
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 8268-8282 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Morbillivirus infection of the mouse central nervous system induces region-specific upregulation of MMPs and TIMPs correlated to inflammatory cytokine expression | |
| P478 | volume | 75 | |